Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / annovis doubles as lead drug improves parkinson s

ANVS - Annovis doubles as lead drug improves Parkinson's

July, 02 2024 02:30 PM Annovis Bio Inc.

2024-07-02 14:30:51 ET

More on Annovis Bio

Annovis: Strong Sell Reiteration Prior To Phase 3 Data In Parkinson's Disease
Annovis Bio: Alzheimer's Disease Topline Data Disappoints The Market
Impact Of Buntanetap Trial Results On Annovis Bio Stock And Future Prospects
Annovis Bio files patent for new manufacturing process of buntanetap
Annovis Bio to post late-stage data for Parkinson's drug in June

For further details see:

Annovis doubles as lead drug improves Parkinson’s

Stock Information

Company Name:	Annovis Bio Inc.
Stock Symbol:	ANVS
Market:	OTC
Website:	annovisbio.com

ANVS ANVS Quote ANVS Short ANVS News ANVS Articles ANVS Message Board

Get ANVS Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.